Skip to content

*The reproducibility of the energy cost of walking test and the 6-minute walk test to assess the physical strain of walking in post-poliomyelitis syndrome patients'

*The reproducibility of the energy cost of walking test and the 6-minute walk test to assess the physical strain of walking in post-poliomyelitis syndrome patients' - Physical strain of walking in patients with PPS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON41241
Enrollment
80
Registered
2012-02-21
Start date
2012-05-09
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpoliomyelitis Syndrome PPS

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients: -a confirmed history of paralytic poliomyelitis -capable of walking independently for more than 150m without any supportive devices -aged between 18 and 75 years;Control subjects: -healthy volunteers, matched for age, gender, body weight and height.

Exclusion criteria

Exclusion criteria: Patients en control subjects: -cognitive impairment -insufficient mastery of the Dutch language -impairments that could contra indicate performing a 6-minute walk test

Design outcomes

Primary

MeasureTime frame
The primary study parameters are speed (in m/min), the 6-minute walking distance (6MWD in m), heart rate (HR in b/min), and EC walking (in J/kg/m), as measured with the ECWT. From the 6MWT, speed, 6MWD, and HR will be calculated.

Secondary

MeasureTime frame
Secondary study parameters are the patient*s perceived exertion score (as measured with the Borg scale), and the patient*s perceived fatigue (as measured with the FSS, DEFS and CIS). FSS = Fatigue Severity Scale DEFS = Dutch Exertion Fatigue Scale CIS = Checklist Individual Strength

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)